N

NRX Pharmaceuticals
D

NRXP

2.12500
USD
-0.11
(-4.71%)
مغلق
حجم التداول
7,444
الربح لكل سهم
0
العائد الربحي
-
P/E
-1
حجم السوق
62,910,944
أصول ذات صلة المقالات

العنوان: NRX Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.